Why Suboxone Causes Constipation

Suboxone contains buprenorphine and naloxone, and the buprenorphine component is a partial opioid agonist that activates mu-opioid receptors throughout the body. While this action is therapeutic for treating opioid dependence, it also affects the gastrointestinal tract in ways that slow digestive function.

Mu-opioid receptors are abundant in the gut, and their activation reduces the rhythmic contractions (peristalsis) that move food through the digestive system. This slowing of intestinal motility is the primary mechanism behind opioid-induced constipation, which affects patients taking any opioid medication, including buprenorphine.

Buprenorphine also increases water absorption from the intestinal contents, making stools harder and more difficult to pass. The combination of slowed transit and drier stool creates the characteristic constipation that many Suboxone patients experience.

The naloxone component in Suboxone was included partly to counteract opioid effects in the gut when taken sublingually as directed. However, the amount of naloxone that reaches the GI tract through sublingual absorption is often insufficient to fully prevent constipation.

Constipation from Suboxone is one of the most common side effects reported by patients and can range from mild inconvenience to a significant quality-of-life issue. Addressing it proactively is important because chronic constipation can lead to complications if left unmanaged.

How Common Is Suboxone Constipation?

Clinical studies and patient reports consistently identify constipation as one of the most frequent side effects of buprenorphine-containing medications. Estimates suggest that 20 to 40 percent of patients taking Suboxone experience clinically significant constipation.

The severity tends to be dose-related, with patients on higher doses of Suboxone generally experiencing more pronounced GI effects. However, even patients on relatively low maintenance doses can develop constipation, particularly in the early weeks of treatment.

Constipation often appears soon after starting Suboxone and may persist throughout the duration of treatment. Unlike some side effects that diminish as the body adapts to the medication, opioid-induced constipation frequently does not resolve on its own without active management.

Patients who were previously taking full opioid agonists before switching to Suboxone may have already been managing opioid constipation. The transition to buprenorphine may improve constipation somewhat compared to full agonists, but it rarely eliminates the issue entirely.

Some patients are reluctant to report constipation to their physician because they consider it a minor issue. However, chronic constipation can lead to hemorrhoids, anal fissures, fecal impaction, and significant abdominal discomfort if not addressed.

Dietary Strategies for Relief

Increasing dietary fiber intake is the most fundamental approach to managing Suboxone constipation. Fiber adds bulk to the stool and helps retain moisture, which promotes easier passage through the intestines. Good sources include vegetables, fruits, legumes, and whole grains.

Adequate water intake is essential for fiber to work effectively. Patients should aim for at least eight glasses of water per day, and more if they are increasing their fiber intake. Fiber without sufficient water can actually worsen constipation by creating dry, bulky stool.

Prunes and prune juice contain natural sorbitol, which acts as an osmotic laxative by drawing water into the intestinal lumen. Many patients find that a small glass of prune juice daily provides meaningful relief without the need for medication.

Regular meal timing helps establish predictable digestive patterns. Eating meals at consistent times each day supports the body’s natural gastrocolic reflex, which triggers intestinal movement after eating, particularly after breakfast.

Limiting constipating foods can also help. Excessive dairy, processed foods, white bread, and red meat tend to slow digestion. Reducing these while increasing fruits, vegetables, and whole grains creates a dietary pattern that supports regular bowel function.

Over-the-Counter Remedies

Stool softeners like docusate sodium (Colace) work by drawing water into the stool to make it softer and easier to pass. Stool softeners are gentle, well-tolerated, and can be taken daily as a preventive measure rather than waiting for constipation to become severe.

Osmotic laxatives such as polyethylene glycol (MiraLAX) and magnesium citrate draw water into the intestines to promote bowel movements. Polyethylene glycol is tasteless when dissolved in water and can be used regularly for opioid-induced constipation.

Fiber supplements like psyllium husk (Metamucil) or methylcellulose (Citrucel) can supplement dietary fiber intake. These should always be taken with plenty of water, and patients should start with a low dose to avoid bloating and gas.

Stimulant laxatives such as bisacodyl (Dulcolax) or senna work by directly stimulating intestinal contractions. While effective, these should generally be used on an as-needed basis rather than daily, as long-term stimulant laxative use can lead to the bowel becoming dependent on them.

Magnesium supplements, particularly magnesium citrate or magnesium oxide, have natural laxative properties. These can serve double duty for patients who also want the general health benefits of magnesium supplementation.

Prescription Options for Persistent Constipation

For patients whose constipation does not respond adequately to dietary changes and over-the-counter remedies, prescription medications specifically designed for opioid-induced constipation are available.

Methylnaltrexone (Relistor) is a peripheral mu-opioid receptor antagonist that blocks opioid effects in the gut without crossing the blood-brain barrier. This means it can relieve constipation without affecting the therapeutic action of Suboxone in the brain.

Naloxegol (Movantik) works through a similar peripheral opioid antagonist mechanism and is taken as a daily oral tablet. Both methylnaltrexone and naloxegol represent targeted approaches to opioid-induced constipation that address the underlying mechanism rather than just the symptoms.

Lubiprostone (Amitiza) is a chloride channel activator that increases fluid secretion in the intestines. While not specific to opioid-induced constipation, it has FDA approval for this indication and can be effective for some patients.

Patients should discuss persistent constipation with their prescribing physician, who can evaluate whether a prescription option is appropriate and ensure there are no interactions with other medications in the patient’s regimen.

Exercise and Lifestyle Modifications

Regular physical activity is one of the most effective non-pharmacological approaches to managing constipation. Exercise stimulates intestinal motility through direct mechanical effects on the abdomen and through activation of the parasympathetic nervous system.

Walking for 20 to 30 minutes daily can produce meaningful improvement in bowel regularity for many patients. The activity does not need to be vigorous — moderate, consistent movement is more beneficial than occasional intense exercise.

Establishing a regular bathroom routine supports the body’s natural elimination patterns. Sitting on the toilet at the same time each day, typically after breakfast when the gastrocolic reflex is strongest, can help train the bowel toward regularity.

Proper positioning during bowel movements can also help. Elevating the feet on a small stool while seated on the toilet straightens the anorectal angle and makes elimination easier. This position mimics a squatting posture and reduces the need to strain.

Stress management is indirectly relevant because stress activates the sympathetic nervous system, which slows digestive function. Practices that promote parasympathetic activity, such as deep breathing and relaxation, can support overall digestive health.

When to Talk to a Doctor About Constipation

Patients should contact their physician if they have not had a bowel movement in three or more days despite using basic management strategies. Prolonged constipation can lead to fecal impaction, which may require medical intervention.

Severe abdominal pain, vomiting, rectal bleeding, or a noticeable change in stool caliber (pencil-thin stools) warrant prompt medical evaluation to rule out conditions beyond opioid-induced constipation.

If constipation is significantly affecting quality of life despite consistent use of dietary modifications and over-the-counter remedies, this should be discussed with the prescribing physician. Adjusting the Suboxone dose or adding a prescription constipation medication may be appropriate.

Mark Leeds, D.O. provides Suboxone treatment for opioid dependence via telemedicine and addresses medication side effects including constipation as part of ongoing patient care. Dr. Leeds works with each patient to find a management approach that maintains treatment effectiveness while minimizing GI side effects.

Patients receiving Suboxone treatment or considering it can schedule a telemedicine consultation with Dr. Leeds to discuss treatment options and side effect management.